PV
Therapeutic Areas
Aelis Farma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AEF0117 | Cannabis-related disorders (Cannabis Use Disorder) | Phase 2b |
| AEF0217 | Cognitive disorders (initially Down syndrome) | Phase 1/2 |
| New CB1-SSi | Other cannabinoid-dependent diseases | Discovery |